Arrowhead Pharma ARWR is set to give its latest quarterly earnings report on Tuesday, 2024-11-26. Here's what investors need to know before the announcement.
Analysts estimate that Arrowhead Pharma will report an earnings per share (EPS) of $-1.05.
The market awaits Arrowhead Pharma's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
The company's EPS missed by $0.83 in the last quarter, leading to a 9.44% drop in the share price on the following day.
Here's a look at Arrowhead Pharma's past performance and the resulting price change:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.55 | -0.16 | -0.82 | -0.60 |
| EPS Actual | -1.38 | -1.02 | -1.24 | -1.02 |
| Price Change % | -9.0% | -11.0% | -5.0% | -27.0% |
Arrowhead Pharma Share Price Analysis
Shares of Arrowhead Pharma were trading at $18.54 as of November 22. Over the last 52-week period, shares are down 35.89%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Arrowhead Pharma visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
